Healthcare
Clinical-stage immuno-oncology company Agenus builds on Genedata’s E2E biopharma discovery system to streamline cancer immunotherapy R&D
Elucid is continuing a series of robustness tests on its smart pill bottle – Pill Connect – which have reported 100 % reliability.
Data show that the implantation procedure of the Genio® system is relatively non-invasive
SkinBioTherapeutics has announced its full year results and released details of its strengthened board and management team following the appointment of Stuart Ashman CEO.
Researchers found that the treatment delayed the development of ALS symptoms in the mice with the ALS mutations.
BrainStorm’s Chief Operating and Chief Medical Officer, Ralph Kern MD MHSc, will make a podium presentation at Clinical Trials Session
Surface Oncology announced that Jeff Goater, chief executive officer, and Vito Palombella, Ph.D., chief scientific officer, will participate in a fireside chat at the Evercore ISI 2nd Annual HealthCONx Conference.
CGuard™ EPS clinical data featured as a prominent discussion point in multiple key presentations
Harpoon Therapeutics, Inc. announced that Gerald McMahon, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 31st Annual Piper Jaffray Healthcare Conference.
INmune Bio’s CEO, Dr. R.J. Tesi, will moderate a panel of experts from neuroscience research, clinical trials, and Alzheimer’s drug development.
PRESS RELEASES